U

Universal Research Group, LLC | Tacoma, WA

Research site
(Unclaimed)
Location
2201 South 19th Street suite 202, Tacoma, Washington, United States of America
Site insights

Top conditions

Cardiovascular Diseases (3 trials)

Dyslipidemias (2 trials)

Kidney Diseases (1 trial)

Alzheimer Disease (1 trial)

Clostridium Infections (1 trial)

Top treatments

Bococizumab
BI 690517
Obicetrapib
LY2623091
TRx0237
Metformin
Apixaban
Vupanorsen
Empagliflozin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 10
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Placebo
Drug: Apixaban Placebo

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with underlying heterozygous familial hypercholester...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Dyslipidemias
Drug: Obicetrapib
Drug: Placebo

Trial sponsors

Pfizer logo

Pfizer (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems